A clinical trials of non-invasive blood glucose monitoring apparatus ~ in use of improved measuring technique ~
Not Applicable
- Conditions
- adults
- Registration Number
- JPRN-UMIN000026024
- Lead Sponsor
- SEIKO EPSON corporation
- Brief Summary
Blood glucose measurement using a non-invasive blood glucose apparatus, which is being developed by Seiko Epson, is still inadequate in terms of accuracy, and it was judged that clinical application of this device was difficult.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) less than Hb (hemoglobin) 13.0 g/dL 2) under taking anticoagulant medicine. 3) A person who is judged for having risk in taking 75g glucose by a participating doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method An assessment of blood glucose levels calculated by the wavelength apparatus.
- Secondary Outcome Measures
Name Time Method An assessment of fluctuation in concentrations of lipid, electrolytes, hemoglobin, and protein, in glucose and diet tolerance tests.